Quick Takeaways
- NPCE - NeuroPace Inc financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2026.
- Headline metric: Return On Equity -159%.
- Info
- Insider Trading
- Financials
- Holders
NeuroPace Inc financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.
- Symbol
- NPCE on Nasdaq
- Location
- Mountain View, CA
- Fiscal year end
- 31 December
- Latest financial report
- 03 Mar 2026
What Changed
- Return On Equity YoY change: <span class="text-red-600">-16%</span>.
- Most recent SEC facts end date: 27 Feb 2026.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2026-02-27) highlights Return On Equity -158.7%, Return On Assets -21.4%, and Operating Margin -16.3%.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
34.2/100
Weak Confidence high
Return On Equity
-159%
Metric score 0.0/100
Return On Assets
-21%
Metric score 0.0/100
Financial Health
- Current Ratio
- 5.28x
- Quick Ratio
- 4.25x
- Debt to Equity
- 4.28x
Strengths
Revenues YoY and NetIncomeLoss YoY
Watchpoints
Return On Equity, Return On Assets, and Operating Margin
Key metrics snapshot
Return On Equity
-159%
YoY: -16%
Industry median: -17% (n=179)
Return On Assets
-21%
YoY: -20%
Industry median: -34% (n=178)
Operating Margin
-16%
YoY: -40%
Industry median: -18% (n=127)
Current Ratio
5.28x
YoY: -1.6%
Industry median: 2.36x (n=176)
Quick Ratio
4.25x
YoY: -1.8%
Industry median: 1.49x (n=146)
Debt-to-equity
4.28x
YoY: -47%
Industry median: 0.46x (n=133)
Revenues YoY
25%
YoY:
Industry median: 15% (n=128)
NetIncomeLoss YoY
21%
YoY:
Industry median: 0.49% (n=168)
Profitability
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | -159% | -16% |
| Return On Assets | -21% | -20% |
| Operating Margin | -16% | -40% |
Financial Health
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 5.28x | -1.6% |
| Quick Ratio | 4.25x | -1.8% |
| Debt-to-equity | 4.28x | -47% |
Growth
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | 25% | |
| NetIncomeLoss YoY | 21% |
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 33,666,948 | +3.4% |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY